glp-1 and sleep apnea Impact of Glucagon-Like Peptide-1 Analogues in the Treatment of Obstructive Apnoea: A Pro/Con Debate Sleep Apnea and GLP-1 Medications

Scott LJ

Clinical trials have found that the A 2A R antagonist istradefylline decreases dyskinesia in PD and could be used as an adjuvant to levodopa treatment

This raises potential concerns for patients with pancreatic and gastrointestinal neuroendocrine cancer or those with genetic conditions like multiple endocrine neoplasia syndrome (MEN1), which predispose individuals to NENs

Asia Pacific is the fastest-growing region in the GLP-1 analogues market, propelled by the rising incidence of lifestyle-related disorders, expanding healthcare access, and a growing middle-class population seeking advanced therapies

United European Gastroenterol J

But before we set a goal weight, we need to make sure youre a good candidate for these drugs